trending Market Intelligence /marketintelligence/en/news-insights/trending/NQFMHQBgPFkhUWebQ4M0Sw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

IBio regains compliance with NYSE American's listing standards

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


IBio regains compliance with NYSE American's listing standards

NYSE American LLC informed iBio Inc. that the company had regained compliance with all of the stock exchange's listing standards.

The New York-based biotechnology company received a noncompliance notice in June after its stockholders' equity fell below the exchange's minimum requirement of $6 million and it booked net losses in five of its most recent fiscal years.

In August, NYSE American accepted iBio's plan to regain compliance with the stock exchange, which had a deadline of Dec. 6, 2019.

IBio provides product development and manufacturing services to clients, collaborators, and third-party customers.